Pneuma Therapeutics Partners With MED Alliance to Expand Distribution of xchange™ Anesthesia Airway Management Device

Partnership Expands Access to xchange™ for Anesthesia Providers Across Hospitals and Ambulatory Surgery Centers

SAN DIEGO, CA, UNITED STATES, October 8, 2026 /EINPresswire.com/ -- Pneuma Therapeutics, an innovative medical device company focused on advancing airway management solutions, today announced a strategic distribution partnership with MED Alliance Group to expand commercial access to xchange™, its innovative, single-use, noninvasive nasal continuous positive airway pressure (CPAP) device designed for perioperative airway management.

Through this partnership, MED Alliance will leverage its established distribution network and relationships with healthcare providers to introduce xchange™ to hospitals, ambulatory surgery centers (ASCs), and anesthesia professionals across its territories.

Advancing Airway Management Through Innovation
Maintaining airway patency and adequate oxygenation during anesthesia and procedural sedation remains a critical challenge, particularly among patients with obesity, obstructive sleep apnea (OSA), and other risk factors for airway obstruction.

Pneuma Therapeutics developed xchange™ to address these challenges by providing anesthesia professionals with a practical, noninvasive approach to delivering positive airway pressure while supporting spontaneous ventilation. Unlike conventional oxygen delivery systems, xchange™ is designed to provide measurable, adjustable positive airway pressure through an innovative nasal interface.

Key features of xchange™ include:
-Noninvasive Nasal CPAP: Supports airway patency and oxygenation during anesthesia and procedural sedation.
-Adjustable Positive Airway Pressure: Delivers pressures up to 20 cmH₂O through an integrated adjustable pressure-limiting (APL) valve.
-Real-Time Pressure Visualization: An integrated manometer allows clinicians to monitor delivered airway pressure.
-EtCO₂ Monitoring Capability: Supports continuous end-tidal carbon dioxide monitoring to assess ventilation.
-Single-Use, Universal Design: A streamlined, disposable solution designed to simplify inventory management and clinical workflow.
-No Capital Equipment Required: Connects to existing medical oxygen sources, allowing implementation without specialized capital equipment.

The device is designed to integrate into existing anesthesia workflows while offering clinicians greater control and visibility over positive airway pressure delivery.

Expanding Commercial Reach Through MED Alliance
MED Alliance brings established relationships with hospitals, surgery centers, and healthcare professionals, along with extensive experience introducing innovative medical technologies to clinical environments.The partnership represents an important step in Pneuma Therapeutics' commercial growth strategy, providing an expanded sales and distribution infrastructure to accelerate market awareness, product evaluations, and adoption.

"At Pneuma Therapeutics, our mission is to provide anesthesia professionals with innovative solutions that improve the way they manage patient airways," said Marc Flaim, CEO, Pneuma Therapeutics. "Partnering with MED Alliance allows us to significantly expand our reach and introduce xchange™ to more clinicians who are seeking effective, practical alternatives for perioperative airway management."

Mike Schroeder, President of Med Alliance Group added, "We are excited to partner with Pneuma Therapeutics to bring xchange™ to our healthcare customers. Its innovative design and clinical functionality represent a valuable addition to our portfolio of medical technologies, and we look forward to supporting its introduction and market adoption across our distribution network."

Supporting the Evolving Needs of Anesthesia Providers
As healthcare facilities continue to prioritize patient safety, procedural efficiency, and cost-effective care, technologies that integrate easily into established clinical workflows are increasingly important. With its disposable design, adjustable positive airway pressure, integrated monitoring capabilities, and compatibility with existing oxygen infrastructure, xchange™ offers a differentiated approach to perioperative airway management.

The Pneuma Therapeutics and MED Alliance partnership reflects a shared commitment to bringing innovative medical technologies to the healthcare professionals and patients who can benefit from them.

About Pneuma Therapeutics
Pneuma Therapeutics is a San Diego-based medical device company dedicated to developing innovative solutions for airway management. Its flagship product, xchange™, is a single-use, noninvasive nasal CPAP device designed to support airway management during anesthesia and procedural sedation. The company focuses on practical technologies that support patient care and clinical efficiency.

About MED Alliance
MED Alliance Group is a medical device distribution organization specializing in bringing innovative healthcare technologies to hospitals, surgery centers, and medical professionals. Through its established distribution network and experienced sales organization, MED Alliance connects medical device manufacturers with healthcare providers across its served markets.

Media Contact

Pneuma Therapeutics
Brian Colby, Chief Operating Officer
brian.colby@pneumatx.com
760-707-7659
http://www.xchangebypneuma.com

MED Alliance Group
Christie Penzol
cpenzol@medalliancegroup.com
https://www.medalliancegroup.com/

Brian Colby
Pneuma Therapeutics, Inc.
+1 760-707-7659
Visit us on social media:
LinkedIn
YouTube